New Mountain Capital Acquires Aceto Chemicals Business

New Mountain-backed Actylis Integrates Aceto and 10 Specialty Ingredients Businesses

September 26, 2022

Manufacturing

New Mountain Capital’s new platform Actylis launched by combining Aceto and ten acquired specialty ingredient manufacturers and sourcing firms into a single global company. The combined business unites GMP and non‑GMP manufacturing, R&D, quality and sourcing capabilities across multiple countries to supply critical raw materials for pharmaceuticals, nutrition, cosmetics, agriculture and specialty chemicals.

New Mountain Capital to Acquire PerkinElmer's Applied, Food and Enterprise Services Businesses

August 1, 2022

Medical Devices

New Mountain Capital entered into a definitive agreement to acquire PerkinElmer's Applied, Food and Enterprise Services businesses (a carve-out from PerkinElmer's Discovery & Analytical Solutions segment) for up to $2.45 billion. The transaction transfers the OneSource lab and field services business and a portfolio of instruments, consumables and reagents to New Mountain, which intends to invest behind the business as a platform for growth; the deal closed in Q1 2023 subject to customary approvals.

Aceto Consolidates Acquisition of Six Specialty Manufacturers

January 26, 2022

Pharmaceuticals

Aceto has consolidated and integrated six recent manufacturing-related acquisitions — A&C, A&C Bio Buffer, Cascade Chemistry, Finar, Islechem and Syntor Fine Chemicals — to create a hybrid manufacturing/distribution model that strengthens its GMP manufacturing, R&D and supply-chain capabilities across pharmaceuticals, biopharma, vaccines, nutraceuticals, agri-science and specialty chemicals. The acquisitions expand Aceto’s global manufacturing footprint (North America, Europe and Asia), broaden its portfolio of excipients, APIs and process solutions, and improve supply-chain resilience for customers.

Aceto Acquires Cascade Chemistry

June 2, 2021

Pharmaceuticals

Aceto, a global provider of specialty materials for life sciences and advanced technology end markets, acquired Eugene, Oregon-based Cascade Chemistry, a CDMO specializing in active pharmaceutical ingredients (APIs) and advanced intermediates. The acquisition strengthens Aceto's U.S. cGMP custom manufacturing capabilities and expands North American API manufacturing capacity; Cascade Chemistry recently announced a facility expansion that will triple its clinical-stage API capacity.

Aceto Acquires A&C (A&C Bio-Buffer)

April 15, 2021

Pharmaceuticals

Aceto has acquired A&C, a global GMP manufacturer of specialty excipients, buffers and process solutions, expanding Aceto's self-manufacturing and custom product capabilities for the vaccine, cell culture and biopharmaceutical markets. The deal adds GMP manufacturing, packaging and ingredient offerings and expands Aceto's North American and European footprint; financial terms were not disclosed.

Aceto Acquires IsleChem to Add U.S. Manufacturing and R&D Capabilities

December 21, 2020

Manufacturing

Aceto U.S., LLC has acquired IsleChem, a Grand Island, New York-based chemical manufacturer and contract R&D provider. The acquisition adds U.S. manufacturing, analytical and R&D capabilities to Aceto’s global specialty-chemicals sourcing and distribution platform and supports expansion of IsleChem’s facility and workforce.